Drug Shortage Report for POSANOL
Report ID | 244157 |
Drug Identification Number | 02432676 |
Brand name | POSANOL |
Common or Proper name | posaconazole Solution for Injection |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | POSACONAZOLE |
Strength(s) | 300MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 18MG/ML 300MG |
ATC code | J02AC |
ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-12-13 |
Actual start date | |
Estimated end date | 2025-01-17 |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2024-11-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-11-29 | French | Compare |
v1 | 2024-11-29 | English | Compare |
Showing 1 to 2 of 2